Ritholtz Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.35M Sell
6,366
-2,277
-26% -$1.28M 0.05% 281
2026
Q1
$4.86M Sell
8,643
-531
-6% -$341K 0.08% 170
2025
Q4
$6.21M Buy
9,174
+489
+6% +$333K 0.11% 113
2025
Q3
$5.55M Buy
8,685
+7,773
+852% +$4.72M 0.11% 114
2025
Q2
$489K Sell
912
-36
-4% -$17.2K 0.01% 648
2025
Q1
$398K Sell
948
-8
-0.8% -$3.47K 0.01% 654
2024
Q4
$395K Buy
956
+291
+44% +$128K 0.01% 628
2024
Q3
$336K Sell
665
-8
-1% -$3.89K 0.01% 670
2024
Q2
$328K Sell
673
-195
-22% -$97.9K 0.01% 632
2024
Q1
$469K Buy
868
+5
+0.6% +$2.73K 0.02% 536
2023
Q4
$479K Sell
863
-1
-0.1% -$469 0.02% 499
2023
Q3
$378K Sell
864
-7
-0.8% -$3.49K 0.02% 503
2023
Q2
$437K Buy
871
+29
+3% +$13.9K 0.02% 460
2023
Q1
$421K Sell
842
-77
-8% -$36.8K 0.02% 445
2022
Q4
$375K Sell
919
-705
-43% -$274K 0.02% 418
2022
Q3
$529K Sell
1,624
-89
-5% -$32.7K 0.03% 385
2022
Q2
$601K Buy
1,713
+287
+20% +$117K 0.04% 276
2022
Q1
$780K Sell
1,426
-375
-21% -$197K 0.05% 226
2021
Q4
$1.19M Buy
1,801
+197
+12% +$124K 0.07% 140
2021
Q3
$998K Buy
1,604
+296
+23% +$199K 0.07% 142
2021
Q2
$826K Buy
1,308
+428
+49% +$236K 0.06% 174
2021
Q1
$431K Buy
880
+240
+38% +$120K 0.04% 232
2020
Q4
$320K Buy
+640
New +$286K 0.03% 243

Other funds holding IDXX

Ritholtz Wealth Management's IDXX Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Idexx Laboratories (IDXX) stake by 26% in Q2 2026, selling an estimated $1.28M and leaving 6,366 shares worth $3.35M. The position accounts for 0.05% of the portfolio, ranked #281.

Ritholtz Wealth Management first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.21M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ritholtz Wealth Management held 6,366 shares of Idexx Laboratories worth $3.35M as of Q2 2026.
  • Ritholtz Wealth Management sold 2,277 Idexx Laboratories shares in Q2 2026, an estimated $1.28M.
  • Idexx Laboratories made up 0.05% of Ritholtz Wealth Management's portfolio in Q2 2026, its #281 holding.
  • Ritholtz Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Ritholtz Wealth Management's Idexx Laboratories position peaked at $6.21M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.